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Background: Under-diagnosis and under-treatment of childhood asthma were investigated in France using data
collected during the 6 Cities Study, the French contribution to the International Study of Asthma and Allergies in
Childhood.
Methods: 7,781 schoolchildren aged between 9 and 10 years underwent a medical visit including skin prick tests
to common allergens and exercise test for Exercise-Induced Asthma (EIA) and their parents filled in a standardized
questionnaire on asthma, management, treatment and potential risk factors.
Results: 903 children reported asthma (11.6%), 377 without a doctor’s diagnosis. Of the 526 participants with a
diagnosis of asthma confirmed by a doctor (58.2%), 353 were treated and 76 were not treated during the year
preceding the investigation despite their diagnosis. The information on the treatment was missing for the rest
of individuals diagnosed with asthma (n = 97). Having a treatment was significantly associated with severe
asthma and with the presence of other respiratory and allergic stigmata (atopic eczema, rhinitis, positive skin
allergy tests, and EIA). In addition, having a treatment did not correspond to a good control of the disease.
Similarly, children with asthma-like symptoms but without doctor-diagnosed asthma had asthma less well
controlled than children with diagnosed asthma. They were also more exposed to passive smoking and traffic
but had fewer pets. In contrast, diagnosed children reported more frequently a small weight at birth and a
preterm birth.
Conclusions: In France, childhood asthma is still under-diagnosed and under-treated and environmental factors
play a role in these phenomena.
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With about 300 million asthmatics worldwide, asthma
has become very important in public health [1]. Further-
more, asthma is the most common disease in children
with a prevalence varying between countries [2].
In France, nearly 4.15 million people were affected by
this disease in 2006. Asthma affects all age groups but
often occurs during childhood. The latest estimates indi-
cate that 7 to 10% of children and 5 to 6% of adults are* Correspondence: isabella.annesi-maesano@inserm.fr
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distribution, and reproduction in any mediumaffected by an active form of asthmatic disease [3]. There
are more boys under 10 years than girls of the same age
with asthma. Mortality due to asthma mainly affects the
elderly but also children under 15 years [4].
The burden of asthma is relevant for the health system
in terms of both direct (hospitalization and treatment) and
indirect costs (absenteeism in school for the children and
at work for the parents) [5]. Globally, it was estimated that
the costs associated with asthma exceeded those of tuber-
culosis and HIV/AIDS combined [4]. These costs could be
reduced by a diagnosis and more appropriate control of
the disease. However, asthma remains still under-
diagnosed and uncontrolled to a large extent in spite ofd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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data allowing determining whether recommendations are
followed. In most chronic diseases, patient’s education
plays a major role in seeking care, and this should also fol-
low in the management and control of asthma. Indeed, by
acting on the diagnosis, care and patient education, it
seems possible to reduce the burden associated with
asthma [7].
Several studies have attempted to show why the asthma
care was absent or delayed. They have all bowed down to
the complexity of the topic. Actually, the management of
the asthmatic disease remains a complex subject since it
depends on a multitude of factors including the perception
of parents, children, educators, and health professionals, as
well as the availability of resources and adherence to treat-
ment [8]. However, few factors have been studied in detail.
In particular, very few investigations have considered the
impact of physical environmental factors on asthma
management.
Using data from the French 6 Cities Study conducted in
a large population-based sample of primary schoolchildren
residing in metropolitan France, we aimed at identifying
risk factors associated with the presence or absence of
asthma diagnosis and treatment as important constituents
in the management of childhood asthma. The considered
factors were individual, socio-demographic, clinical and
environmental and included the early life window of ex-
posure. The long-term purpose of our study is to under-
stand what interventions are necessary to achieve optimal
management of asthmatic disease.
Methods
Protocol and population
Through the 6 Cities Study, the French section of the sec-
ond phase of ISAAC investigation conducted in France in
2000–1, 9,615 primary schoolchildren were invited in the
six French cities (Bordeaux, Clermont-Ferrand, Créteil,
Marseille, Strasbourg and Reims) to undergo clinical tests
and their parents to complete a standardized medical
questionnaire derived from the International ISAAC ques-
tionnaire [9]. The clinical tests, performed at school by
qualified physicians, included a skin examination to detect
atopic eczema, a test of bronchial hyperactivity to effort,
and skin prick tests (SPT) to identify the existence of an al-
lergic hypersensitivity.
Questionnaire
The standardized questionnaire included sections on socio-
demographic and risk factors, health (asthma, allergic
rhinitis, eczema, allergies), management, use of care facil-
ities, treatment, compliance, lifestyle, housing, early events
of life. Children were also interviewed also on school absen-
teeism due to asthma. Details of the survey are presented
elsewhere [10].Asthma definition and characterization
Exact standardized questions used to identify through the
questionnaire children with asthma and to characterize
them by the existence of a diagnosis or treatment were:
During the past 12 months, has your child (he/she) ever
had wheezing or whistling in the chest at any time? (“YES”
corresponded to have ever had wheezing or whistling)
Has your child ever had asthma? (“YES” corresponded
to have ever had asthma)
Has your child ever been diagnosed with asthma by a
doctor? (“YES” corresponded to have had a diagnosis of
asthma).
Then, if the child was treated, the question was asked:
During the last 12 months, has your child (he/she) taken
medication for wheezing or asthma also during or after
physical effort? If the answer to this question was “YES”,
the child was considered treated for his/her asthma. If the
answer to this question was “NO”, the child was consid-
ered untreated.
The following three definitions of asthma (statistical
variable) were used in our study:
 "Current asthma" as defined by report of wheezing
or whistling in the chest in the last twelve months
and ever asthma in life (dichotomous variable).
 "Asthma diagnosed by a physician" (dichotomous
variable).
 "Treated asthma" (dichotomous variable).
In addition, to better characterize asthma the following
characteristics were considered:
 Clinical severity of asthma according to GINA
(www.gina.org), the number of crises during the past
12 months, the number of wheezing episodes that
have awakened the child in the last 12 months, the
number of asthma attacks, the number of crises that
prevented him/her from speaking in the past
12 months, the number of wheezing episodes during
or after exercise in the last 12 months,
hospitalization during the last 12 months, and the
number of school days missed in the last 12 months.
 Therapeutic intervention: asthma medication, asthma
attacks prevention by parents, knowledge of
medication to give for asthma attacks by parents,
health care of the child's asthma, including prevention
of asthma attacks, and the use of a peak flow-meter.
Allergic history and Exercise-Induced Asthma (EIA)
 Allergic sensitization was defined on the basis of
positive skin allergy tests. The skin tests were
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ISAAC protocol with indoor and outdoor allergens
(e.g. Dermatophagoides pteronyssinus,
Dermatophagoides farinae, cat hair, Alternaria,
cockroach, grass, etc.) and food allergens (e.g., the
trophoallergenes, milk, fish, eggs, peanuts, etc.), with
a positive and negative control to eliminate false
positives and negatives [10]. Three variables were
considered: the SPT positivity to indoor allergens,
SPT positivity to outdoor allergens, and SPT
positivity to trophoallergens.
 Exercise-induced Asthma (EIA) was assessed by
measuring changes in peak expiratory flow before
and after a running test lasting six minutes. We
defined a test as positive when the peak expiratory
flow rate fell to either less than 10% or less than
15%, respectively. In the analysis, we have used these
two variables: BHR10 (bronchial hyper-
responsiveness to effort with decreased lung
function of 10%) and BHR15 (bronchial hyper-
responsiveness to effort with decreased lung
function of 15%).
 Allergic comorbidities: lifetime eczema, lifetime
allergic rhinitis and other serious health problems.
Studied co-factors
The following factors were considered as co-variables in
the statistical models:
 Individual factors: the city (Bordeaux, Clermont-
Ferrand, Créteil, Marseille, Strasbourg and Reims),
sex, age in years, the Body Mass Index (BMI)
defined by the ratio of weight to height squared in
kg/m2, the heritability of asthma (i.e., maternal
asthma) and number of siblings.
 Socio-demographic factors: ethnicity of the two
parents, educational level of the two parents,
paternal Socio-Economic-Status (SES) as defined by
the classification of INSEE, i.e., the French National
Institute for Statistics (e.g., farmers, employees,. . .),Bordeaux 16.56%
Clermont-Ferrand 16.57%
Strasbourg 16.74%
Figure 1 Geographical distribution in the 6 Cities Study (n = 7,781 paand marital status of the child’s parents and medical
coverage (i.e., health insurance, mutual payment,
free medical care, personal insurance, no welfare at
all) of the family.
 Environmental condition at the period of the survey
(e.g., smoking, pets, housing situation, tasks,
moisture, exposure to traffic, etc.).
 Early life events, i.e., prematurity, birth weight,
breastfeeding.
Dichotomous or categorical variables with the excep-
tion of BMI were considered in the analysis.
Statistical and epidemiological analyses
The type of asthma (“diagnosed or not”, “treated or not”)
was investigated with respect to child’s characteristics,
clinical characteristics of asthma, co-morbidity, asthma
management, environmental exposure at the period of the
survey and early life events in order to identify factors that
were associated with the absence of asthma diagnosis and
treatment. The chi-square test was used to compare per-
centages between groups. Analysis of variance (ANOVA)
was used to compare differences between continuous vari-
ables. Through a logistic regression analysis adjusting for
age, sex, city and BMI, the factors associated with the dif-
ferent types of asthma were identified. Associations were
expressed in terms of Odds Ratios (OR) and 95% confi-
dence intervals (95% CI). The study on the use of asthma
medications was restricted to children diagnosed with
asthma, since not being diagnosed greatly diminished the
chances of being treated for this disease. All statistical ana-
lyses were performed using SAS W version 9.
Results
Out of the 9,615 children in the classes of CM1 and CM2
recruited in 108 schools randomly selected in the 6 Cities,
7,798 were enrolled (Figure 1) for the study. They were
aged between 9–10 years old [10]. The participation rate
varied by city. We report here data for 903 children having
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as asthmatic by a doctor. The remaining 377 children,
while having asthma-like symptoms (e.g., wheezing or
whistling in the chest in the last 12 months) did not re-
ceive a doctor’s diagnosis confirming the existence of
asthma. From a total of 526 children diagnosed with
asthma, 353 were treated for asthma and 76 were not trea-
ted. The information on the treatment was missing for the
remainder of children diagnosed with asthma (n = 97).
Significant geographic differences were observed in the
diagnosis and treatment of childhood asthma based on data
(Table 1). The highest proportion of diagnosed asthma was
seen in Créteil (19.39%), which is a city close to Paris, fol-
lowed closely by Bordeaux (18.72%) and Marseilles
(18.16%). Bordeaux (19.26%), Marseille (18.70%), and
Créteil (18.70%) were the cities where children were the
most treated ones; there were more untreated children
in eastern France than elsewhere (18.42% in Reims and
Strasbourg with 25.00%). After adjustment for potential
confounders, most treated children were from Bordeaux
and Strasbourg (OR) = 2.816, confidence interval 95%
(95% CI): 1.121-7.075, p = 0.0436). The rate of untreated
asthma out of diagnosed asthma varied from 4.7% in Bor-
deaux to 13.4% in Strasbourg (6.1% in Marseilles, 7.4% in
Créteil and 8.8% in Clermont-Ferrand) (Table 1). Compared
to girls, boys were at higher risk not only of reporting more
asthma but also of suffering more of diagnosed and treated
asthma (Table 2). Compared to the entire population, boys
not only reported more asthma (60.35% vs. 39.64%) but
also suffered more from undiagnosed and untreated asthma
than girls (Table 2). Trends were found between asthma
and ethnicity and living only with the mother.Table 1 Geographic distribution of the children in the entire
Entire sample
All Undiagnose
N = 7,781 N = 903 N = 377
N (%)
Créteil 1,420 175 73
(19.59) (19.39) (19.36)
Reims 987 116 40 (10.61)
(13.62) (12.85)
Marseille 1,226 164 69
(16.92) (18.16) (13.12)
Strasbourg 1,213 142 59
(16.74) (15.73) (15.65)
Clermont-Ferrand 1,201 137 62
(16.57) (15.17) (16.45)
Bordeaux 1,200 169 74
(16.56) (18.72) (19.63)
N, number;%, percentage.Diagnosed vs. undiagnosed asthma
Comparing the presence and the absence of a doctor’s
diagnosis of asthma in asthmatics, diagnosed asthma was
found to be less frequent when parents had low education
or a foreign origin (North Africa or Asia). Indeed, asthma
was most frequently diagnosed among children of French
origin (metropolitan France and overseas territories)
(Table 2). No significant association was observed with
other socio-demographic and individual factors (Table 2).
As expected, the treatment varied according to the
presence or the absence of the diagnosis of asthma
(Table 3). Among the diagnosed asthmatics, bronchodi-
lators were the drug class most often used, with 59.32%
of children who had taken at least one drug in this class
(Table 3), followed by inhaled corticosteroids (39.73%).
In the sample of the children not diagnosed with
asthma, there were children who took medication to im-
prove their breathing that required a prescription even
in the absence of a diagnosis of asthma (7.16% were tak-
ing bronchodilators and 11.94% were taking inhaled cor-
ticosteroids) (Table 3).
The clinical comparison between diagnosed and undiag-
nosed asthma showed that among the undiagnosed asth-
matics, 3.98% (vs. 14.07% among diagnosed) were in the
GINA level 2 and 5. 85% (vs. 17.87% among diagnosed) in
level 3 (Table 4). In the last 12 months, 66.22% of undiag-
nosed asthma cases had had one to three crises (vs.
55.14% among diagnosed), 6.54% of children woke up on
one or more nights in a week (vs. 10.29% among diag-
nosed) due to wheezing, 4.05% of children had a severe at-
tack that had prevented him/her from speaking (vs.
10.14% among diagnosed), and 28.87% had missed onepopulation-based sample and in the asthmatics
Asthma
d Diagnosed Diagnosed













Table 2 Characteristics of the children in the entire population-based sample and in the asthmatics
Entire sample Asthma
All(&) Undiagnosed Diagnosed(^) Diagnosed
N = 7,781 N = 903 N = 377 N = 526 Untreated N = 76 Treated(})N = 353
Variable
Age (year, mean ± DS) 10.40 ± 0.75 10.42 ± 0.74 10.40 ± 0.75 10.43 ± 0.74 10.43 ± 0.73 10.43 ± 0.71
Gender, N (%)
Boys 3,872 (49.77) 545 (60.35)* 222 (58.89) 323 (61.41) 45 (59.21) 222 (62.89)
Girls 3,908 (50.23) 358 (39.65) 155 (41.11) 203 (38.59) 31 (40.79) 131 (37.11)
BMI, N (%)
8 Kg/m2 4,751 (61.07) 529 (58.58) 224 (59.42) 305 (57.98) 45 (59.21) 199 (56.37)
18-25 Kg/m2 2,842 (36.53) 347 (38.43) 140 (37.14) 207 (39.35) 27 (35.53) 145 (41.08)
5 Kg/m2 187 (2.40) 27 (2.99) 13 (3.45) 14 (2.66) 4 (5.26) 9 (2.55)
Mother’s asthma, N (%) 521 (7.27) 151 (16.72)* 62 (16.45) 89 (16.92) 10 (13.16) 62 (17.56)
Birth order, First, N (%) 3,940 (55.01) 517 (57.32) 207 (55.05) 310 (58.94) 46 (60.53) 218 (61.76)
Ethnic origin of the parents, N (%)
Metropolitan France 4,272 (54.90) 524 (78.80)* 205 (75.65) 319 (80.96) 49 (84.48) 215 (80.83)
Overseas Departments 98 (1.26) 14 (2.11) 4 (1.48) 10 (2.54) 2 (3.45) 8 (3.01)
South Europe 142 (1.82) 15 (1.78) 8 (2.95) 7 (1.78) 0 5 (1.88)
North Africa 461 (5.92) 57 (7.61) 27 (9.96) 30 (7.61) 4 (6.90) 21 (7.89)
Asia 169 (2.17) 24 (2.79) 13 (4.80) 11 (2.79) 1 (1.72) 7 (2.63)
Sub-Saharian Africa 137 (1.76) 11 (1.78) 4 (1.48) 7 (1.78) 0 5 (1.88)
Others 190 (2.44) 20 (2.54) 10 (3.69) 10 (2.54) 2 (3.45) 5 (1.88)
Education, N (%)
Elementary 599 (9.10) 58 (7.00) 21 (6.03) 37 (7.71) 7 (10.14) 19 (5.88)
Secondary 2745 (41.70) 344 (41.55) 150 (43.10) 194 (40.42) 22 (31.88) 129 (39.94)
High School, College 3,103 (47.14) 404 (48.79) 165 (47.41) 239 (49.79) 38 (55.07) 169 (52.32)
Others 135 (2.05) 22 (2.66) 12 (3.45) 10 (2.08) 2 (2.90) 6 (1.86)
Parental socio-economic status, N (%)
Artisan, own activity 339 (5.33) 39 (4.88) 15 (4.55) 24 (5.11) 2 (2.99) 17 (5.36)
Liberal profession 1,525 (23.97) 185 (23.13) 75 (22.73) 110 (23.40) 14 (20.90) 76 (23.97)
Intermediate profession 1,393 (21.89) 195 (24.38) 73 (22.12) 122 (25.96) 25 (37.31) 83 (26.18)
Employees 1856 (29.17) 228 (28.50) 105 (31.82) 123 (26.17) 11 (16.42) 79 (24.92)
Blue collars 871 (13.69) 98 (12.25) 38 (11.52) 60 (12.77) 12 (17.91) 39 (12.30)*
Farmer, retired, inactive 379 (5.96) 55 (6.88) 24 (7.27) 31 (6.60) 3 (4.48) 23 (7.26)
Medical coverage, N (%)
Social Security 6,846 (87.99) 864 (95.68) 363 (96.29) 501 (95.25) 69 (90.79) 341 (96.60)*
Complementary insurance 5,813 (74.71) 733 (81.17)* 305 (80.90) 428 (81.37) 63 (82.89) 285 (80.74)
Free medical care 514 (6.61) 74 (8.19) 37 (9.81) 37 (7.03) 8 (10.53) 24 (6.52)
Personal insurance 990 (12.72) 106 (11.74) 43 (11.41) 63 (11.98) 14 (18.42) 37 (10.48)
No protection 12 (0.15) 5 (0.55) 1 (0.27) 4 (0.76) 0 2 (0.57)
Type of family, N (%)
Live with his/her 2 parents 5,140 (72.24) 584 (64.82)* 236 (62.93) 348 (66.16) 51 (67.10) 237 (67.14)
Live with his/her mother only 1,487 (20.90) 234 (25.97)* 101 (26.93) 133 (25.29) 17 (22.37) 87 (24.65)
Live with his/her father only 179 (2.52) 23 (2.55) 12 (3.20) 11 (2.09) 1 (1.32) 7 (1.98)
N, number;%, percentage; NS, not significant; (&), p-value between asthmatics and the rest of the population; (^), p-value between diagnosed and un-diagnosed
asthma; (}), p-value between treated and untreated asthma.
*, p < 0.05.
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Table 3 Therapeutic intervention in asthmatics of the 6 Cities Study (n = 903 out of 7,781 participants)
Asthma medication Undiagnosed Asthma N = 377 Diagnosed Asthma N = 526 p-value
Antihistamines h1, N (%) 11 (2.92) 65 (12.36) 0.01
Inhaled Corticosteroids, N (%) 27 (7.16) 209 (39.73) 0.01
Bronchodilators, N (%) 45 (11.94) 312 (59.32) 0.01
Other antihistamines, N (%) 4 (1.06) 42 (7.98) 0.01
Nasal medications, N (%) 0 9 (1.71) NS
Medication against eczema, N (%) 0 3 (0.57) NS
Other medications, N (%) 6 (1.59) 12 (2.28) NS
N, number; NS, not significant;%, percentage.










Asthma severity according to GINA, N (%) *** ***
level 1 340 (90.19) 358 (68.06) 70 (92.11) 202 (57.22)
level 2 15 (3.98) 74 (14.07) 2 (2.93) 71 (20.11)
level 3 22 (5.85) 94 (17.87) 4 (5.26) 80 (22.66)
Number of attacks during the last 12 months, N (%) ** ***
None 53 (23.56) 56 (15.14) 17 (58.62) 21 (6.95)
1 to 3 times 149 (66.22) 204 (55.14) 12 (41.38) 177 (58.61)
4 to 12 times 18 (8.00) 86 (23.24) 0 81 (26.82)
More than 12 times 5 (2.22) 24 (6.46) 0 23 (7.62)
Sleep disturbed due to wheezing, N (%) *
Never 162 (72.70) 200 (57.14) 21 (80.77) 157 (53.58)
Less than a night per week 38 (17.76) 114 (32.57) 3 (11.54) 105 (35.84)
One or more nights per week 14 (6.54) 36 (10.29) 2 (7.69) 31 (10.58)
Asthma attacks, N (%) ***
1 or more crises per month 13 (13.13) 108 (25.71) 1 (1.64) 101 (31.08)
Less than a crisis per month 24 (24.24) 107 (25.48) 5 (8.20) 100 (30.70)
Less than a crisis by year 27 (27.27) 83 (19.76) 11 (18.03) 70 (21.54)
Attacks have disappeared 35 (35.35) 122 (29.05) 44 (72.13) 54 (16.62)
Wheezing ever been severe enough to limit your (child’s) speech in the
last 12 months, N (%)
9 (4.05) 37 (10.14) 1 (3.70) 35 (11.59)
Wheezing during or after effort in the last 12 months, N (%) 106 (29.12) 217 (42.27) 6 (7.89) 200
(58.48%)***
Hospitalization in the last 12 months, N (%) 2 (2.06) 32 (8.94) 0 30 (10.68)
Missed school days, N (%) **
None 69 (71.13) 215 (60.91) 49 (90.74) 152 (53.71)
1-5 days 18 (18.56) 87 (24.65) 2 (3.70) 83 (29.33)
6-10 days 6 (6.19) 36 (10.20) 3 (5.56) 33 (11.66)
More then 11 days 4 (4.12) 15 (4.25) 0 15 (5.30)
N, number; NS, not significant,%, percentage.
(^), p-value between diagnosed and undiagnosed asthma.
(}), p-value between treated and untreated asthma.
*, p < 0.05.
**, p < 0.01.
***p < 0.001.
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Lifetime eczema, N (%) 1,715 (25.22) 359 (41.65) 121 (33.43) 238 (47.60) 27(36.00) 175
(52.24)
0.0110
Lifetime allergic rhinitis, N (%) 1,998 (29.28) 537 (61.72) 196 (54.44) 341 (66.86) 41(55.41) 242
(70.76)
0.0102
Severe health problem, N (%) 287 (4.28) 52 (6.30) 17 (5.04) 34 (7.16) 5(6.85) 23 (7.12)
SPT+ to indoor allergens, N (%) 1,409 (20.95) 342 (45.60) 119 (37.07) 223 (51.98) 20 167 <0.0001
(30.30) (60.29)
SPT+ to outdoor allergens, N
(%)
824 (12.25) 184 (24.53) 56 (17.45) 128 (29.84) 12 95 0.0111
(18.18) (34.30)
SPT+ to food allergens, N (%) 138 (2.05) 60 (4.00) 6 (1.87) 24 (5.59) 2 (3.03)
BRH10, N (%) 610 (8.95) 140 (17.95) 55 (16.72) 85 (18.85) 6 (8.82) 69 (23.31) 0.0077
BRH15, N (%) 227 (3.33) 85 (10.90) 28 (8.51) 57 (12.64) 2 (2.94) 50 (16.89) 0.0030
HBR10, bronchial hyperactivity to effort with respiratory function decreasing of 10%; HBR15, bronchial hyperactivity to effort with respiratory function decreasing
of 15%; SPT +, skin prick test positivity; N, number; NS, not significant;%, percentage.
(&),p-value between asthmatics and the rest of the population.
(^), p-value between diagnosed and undiagnosed asthma.
(}); p-value between treated and untreated asthma.
*, p < 0.05.
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of comorbidities, diagnosed asthmatics were more often
diagnosed with eczema (47.60% vs. 33.43%) and lifetime
allergic rhinitis (66.86% vs. 54.44%) than the undiagnosed




Medication compliance, N (%)
All treatment 34 (73.91)
Most of the treatment 6 (13.04)
A part of the treatment 6 (13.04)
None 0 (0.00)
Attacks prevention, N (%) 33 (31.43)
Medication during asthma attacks, N (%) 68 (64.15)
Management of asthma by the child, N
(%)
21 (23.08)
Peak flow-meter use, N (%) 0 (0.00)
N, number; NS, not significant;%, percentage.
(&), p-value between asthmatics and the rest of the population.
(^), p-value between diagnosed and undiagnosed asthma.
(}), p-value between treated and untreated asthma.
*, p < 0.05.was less important in the undiagnosed asthma group as
shown by lower percentages of medication compliance,
attacks prevention, medication use during asthma attacks,
asthma management and peak flow use in this group











262 (72.58) 6 (50.00) 243
(73.41)
<0.0001
66 (18.28) 1 (8.33) 62 (18.73)
21 (5.82) 0 20 (6.04)
8 (2.22) 4 (33.33) 3 (0.91)
281 (62.86) 31 (45.59) 223
(67.58)
0.0006
423 (91.36) 59 (84.29) 325
(94.20)
0.0040
300 (66.52) 23 (32.39) 258
(77.48)
<0.0001
29 (6.25) 2 (2.99) 25 (7.20) 0.2003
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stop), but had fewer pets than the diagnosed children
(Table 7). In contrast, diagnosed children had a past his-
tory of low birth weight and preterm birth more often
than the undiagnosed ones (Table 8).
Treated vs. untreated asthma
Even among the children not diagnosed with asthma there
were children who took medication (Table 3). There was
no statistical significant difference between treated and un-
treated asthmatics with respect to gender, age and BMI
(Table 2). Asthma was most frequently treated among chil-
dren of French origin (metropolitan France and overseas
territories). There were fewer treated asthma cases when
the educational level of parents was limited to primary edu-
cation (9.10% vs. 5.88%) and a greater proportion of treated
asthma cases for higher levels of parental education






Paternal smoking, N (%) 1,958 (27.31) 251 (27.80)
Maternal smoking, N (%) 2,060 (28.73) 294 (32.56)
Living in, N (%)
Town 4,625 (67.48) 593 (68.79)
Suburb of a town 1,633 (23.83) 199 (23.09)
Village 369 (5.38) 39 (4.52)
Isolated house, farm 227 (3.33) 31 (3.60)
House built, N (%)
Before 1945 1,444 (21.44) 202 (23.71)
Between 1945-1960 832 (12.35) 86 (10.09)
After 1960 3,150 (46.76) 387 (45.42)
Don’t know 1,310 (19.45) 177 (20.77)
Living near bus stops ,N (%) 2,781 (41.07) 358 (41.68)
Gas cooking, heater with evacuation, N
(%)
3,340 (49.10) 424 (49.19)
Conditioned air, N (%) 400 (5.84) 56 (6.50)
Cracked painting at home, N (%) 790 (11.45) 119 (13.63)
Condensation, N (%) 1,225 (18.10) 172 (20.02)
Water leaks, N (%) 551 (7.97) 74 (8.47)
Moulds, N (%) 1,176 (17.02) 166 (19.10)
Pets, N (%) 3,643 (50.81) 406 (44.96)
N, number; NS, not significant;%, percentage.
(&); p-value between asthmatics and the rest of the population.
(^), p-value between diagnosed and un-diagnosed asthma.
(}), p-value between treated and untreated asthma.
*:p < 0.05.population). In addition, medical coverage significantly
influenced the treatment of children since those covered by
the social security system were more treated compared to
the others (p = 0.03). The clinical condition (Table 4) was
certainly the most convincing for getting a treatment
among the asthma cases. Asthmatics with untreated asthma
in most case were on level 1 according to asthma severity
level in GINA (92.11% vs. 57.22%). Children whose clinical
condition was more severe (levels 2 and 3) were more often
treated than those of level 1 (level 2: OR = 11.619, 95% CI:
2.738 – 49.311, p = 0.0009; and level 3: OR = 6.680, 95%
CI: 2.330 – 19.065, p = 0.0004). Nevertheless, there were
still 2.93% of diagnosed asthmatics who were not treated in
the level 2 and 5.26% in level 3. It was observed that the
number of attacks in the last year and the number of
attacks that have awakened the child were highly related to
treatment, with untreated asthma having fewer crises than















113 (29.97) 138 (26.24) 17 (22.37) 97 (27.48) NS




258 (71.67) 335 (66.73) 47 (68.12) 225 (66.37)
76 (21.11) 123 (24.50) 14 (20.29) 90 (26.55)
15 (4.17) 24 (4.78) 4 (5.80) 13 (3.83)
11 (3.06) 20 (3.98) 4 (5.80) 11 (3.24)
92 (26.44) 110 (21.83) 12 (17.14) 77 (22.65) NS
32 (9.20) 54 (10.71) 9 (12.86) 33 (9.71)
144 (41.38) 243 (48.21) 35 (50.00) 164 (48.24)
80 (22.99) 97 (19.25) 14 (20.00) 66 (19.41)
167 (47.18) 191 (37.82) 17 (23.94) 137 (40.41) 0,0092
167 (47.04) 257 (50.69) 35 (48.61) 167 (49.26) NS
23 (6.44) 33 (6.53) 4 (5.41) 18 (5.31) NS
48 (13.26) 71 (13.89) 10 (13.51) 45 (13.12) NS
75 (20.89) 97 (19.40) 13 (18.60) 69 (20.60) NS
30 (8.26) 44 (8.61) 3 (4.05) 30 (8.72) NS
71 (19.72) 95 (18.66) 17 (22.97) 63 (18.48) NS
169 (41.63) 237 (58.37) 32 (42.11) 160 (45.33) NS




















Birth weight, N (%) NS
<2.5 kg 402 (6.16) 61 (7.61) 29 (8.81) 32 (6.77) 2 (2.90) 22 (6.94)
2.5 kg −3.5 kg 4,191 (64.25) 512 (63.84) 224 (68.09) 288 (60.89) 44 (63.77) 192
(60.57)
3.5 kg< 1,930 (29.59) 229 (28.55) 76 (23.10) 153 (32.35) 23 (33.33) 103
(32.49)
Pre-term birth, N (%) 4,829 (25.88) 264 (32.51) 117 (35.35) 147 (30.56) 24 (31.58) 93 (26.35) NS
Breast-fed child, N
(%)
3,709 (54.36) 460 (53.74) 197 (56.29) 263 (51.98) 33 (45.21) 186
(55.36)
0.1150
HBR10, bronchial hyperactivity to effort with respiratory function decreasing of 10%; HBR15, bronchial hyperactivity to effort with respiratory function decreasing
of 15%, NS, not significant; SPT +, skin prick test positivity.
(&), p-value between asthmatics and the rest of the population.
(^), p-value between diagnosed and undiagnosed asthma.
(}), p-value between treated and untreated asthma.
*, p < 0.05.
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hospitalization: 100.00% among non-treated vs. 89.32%
among those treated) and missed more days at school (no
school day missed; 90.74% in untreated vs. 53.71% for trea-
ted). Comorbidities (Table 5) were also factors that were
revealing in our study. Being treated for asthma was
strongly associated with comorbidities, such as lifetime ec-
zema (OR = 2.206, 95% CI: 1.269 – 3.835, p = 0.0050), aller-
gic rhinitis (OR = 3.055, 95% CI: 1.310 – 7.122, p = 0.0097)
and allergic sensitization to indoor allergens (OR = 3.691,
95% CI: 2.024 – 6.734, p = <0.0001), allergic sensitization
to outdoor allergens (OR = 2.458, 95% CI: 1.215 – 4.970,
p = 0.0123), BRH10% (OR = 2.854, 95% CI: 1.157 – 7.040,
p = 0.0228) and BRH15% (OR = 5.950, 95% CI: 1.389 –
25.482, p = 0.0163). The knowledge of the management of
asthma was more frequent in treated children compared
to the others (Table 6). Regarding the environment at the
period of the survey (Table 7), living near a bus stop was
the only factor found to be treatment-related. Among the
events of early life, none influenced the treatment of
asthma (Table 8). However, children who were breastfed
were more frequently treated although only at a border-
line significance (p = 0.11).
All of the factors identified as statistically related to the
treatment for asthma in the univariate analysis remained
statistically significant after adjustment for potential con-
founding factors (Table 9).
Discussion
This study constitutes a preliminary attempt to identify
which factors are associated with the under-diagnosis and
the under-treatment of childhood asthma in Metropolitan
France. Our population-based sample comprised 903asthmatic children at the period of the survey, 58% of
whom had been diagnosed as asthmatic by a doctor. Only
67% of children with a diagnosis of asthma were treated for
their condition. After adjustment for potential confounding
factors, the treatment was significantly related to two para-
meters, clinical status and comorbidities, with the treated
children presenting more severe forms of asthma and more
allergic comorbidities. Of note, there were children in our
population having been diagnosed by a physician as asth-
matics that were not treated for their condition. Essentially
our findings highlight the need to identify populations of
asthmatics most at risk of not being diagnosed and treated
for their conditions. This in a context in which there is evi-
dence that treatment is one effective way to control asthma
[2] together with education, parental education in the case
of young children [11]. Data show that the diagnosis consti-
tutes a first necessary step in getting a treatment.
In our investigation, comorbidities, such as eczema,
rhinitis, and allergic sensitization increased the likelihood
of treatment, as asthma severity did. The treatment in our
population was related to a greater severity, more frequent
asthma attacks, more frequent awakenings due to wheez-
ing, and a higher number of school days missed thus con-
firming previous data [12]. Some children with asthma in
our population were at level 3 of GINA classification, des-
pite their treatment. Previous observations have shown
that patients severely affected by asthma did not tend to
follow the treatment entirely, thus remaining uncontrolled
with asthma [13]. However, children with treated asthma
knew better how to control their asthma and medications
to take in case of crisis attacks in our population. This
seems plausible if there was a contact of the child with a
health professional that led to a better understanding of
Table 9 Factors related to asthma treatment after adjustment on age sex, center and BMI in the asthmatics
Odds Ratio Confidence interval 95% p-value
Centres
Bordeaux vs. Strasbourg 2.816 1.121–7.075 0.0436
Asthma severity
Level 2 vs. Level 1 11.619 2.738–49.311 0.0009
Level 3 vs. Level 1 6.680 2.330–19.065 0.0004
Number of attacks
1 to 3 attacks vs. no crisis 10.202 3.843–27.084 <0.0001
Night awakening
Less than one crisis/week vs. never 4.029 1.139–14.253 <0.0307
Asthma attacks
Less than one attack per year vs. crises have disappeared 4.428 2.017–9.722 0.0002
Less than one attack per month vs. crises have disappeared 16.652 5.948–46.616 <0.0001
1 or more attacks per month vs. crises have disappeared 70.728 9.414–531.388 <0.0001
Wheezing after an exercise 17.384 7.165–42.178 <0.0001
Missed school days
One day and more vs. none 11.480 2.650–49.734 0.0011
Lifetime eczema 2.206 1.269–3.835 0.0050
Lifetime allergic rhinitis 3.055 1.310–7.122 0.0097
SPT Positivity to indoor allergens 3.691 2.024–6.734 <0.0001
SPT Positivity to outdoor allergens 2.458 1.215–4.970 0.0123
HBR10 2.854 1.157–7.040 0.0228
HBR15 5.950 1.389–25.482 0.0163
Medication compliance
Most of the treatment vs. nothing 37.648 1.742–813.854 0.0207
All treatment vs. nothing 36.005 3.169–409.117 0.0039
Attacks prevention 2.311 1.317–4.054 0.0035
Medication during asthma attacks 2.857 1.222–6.680 0.0154
Management of asthma by the child 6.697 3.702–12.113 <0.0001
Living near a bus stop 2.423 1.298–4.522 0.0055
HBR10, bronchial hyperactivity to effort with respiratory function decreasing of 10%; HBR15, bronchial hyperactivity to effort with respiratory function decreasing
of 15%; SPT +, skin prick test positivity.
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proposed a patient-physician partnership for a better pre-
vention of asthma. Another argument in favor of under-
treatment of asthma in our population is provided by the
type of treatment used. There was a majority of children
taking bronchodilators for both attacks prevention and/or
attacks, which does not seem appropriate in the light of
existing data [14].
In this same population-based sample, we had observed
an increased risk of asthma and allergies in children living
close to areas with elevated concentrations of traffic-related
pollutants [15]. We also found that almost a third of the chil-
dren had lived all their life at the same address and thereafter
were exposed through their life to elevated levels of traffic-related air pollutants. Proximity of an asthmatic’s house to a
bus stop was an indicator whether he/she had more severe
asthma and was more often treated. Several studies have
shown that urban traffic is associated with increased respira-
tory symptoms and a greater use of treatment probably be-
cause of the action of traffic-related pollutants [16].
Our study also investigated the characteristics of the
asthmatic population for whom no diagnosis was made.
With one third of asthmatics-or 377 individuals-undiag-
nosed, our work shows that childhood asthma is still an
under-diagnosed condition in France and that this situ-
ation can be detrimental. Indeed, children with asthma
symptoms without a diagnosis had a less well controlled
asthma than children with diagnosed asthma in our
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the reduced use of health care in some subjects, but also
secondary to the use of differential diagnoses (e.g., bron-
chitis, asthmatic bronchitis, etc.) from the doctor since
some of these children were taking drugs to improve
their breathing [17]. Undiagnosed asthmatics in the 6
cities showed allergic sensitization and bronchial hyper-
responsiveness (i.e., bronchospasm during exercise),
known to be risk factors for asthma. The links between
asthma and other allergies are already known, but have
rarely been connected with the under-diagnosis and
under-treatment of asthma. Allergic rhinitis and eczema
are associated with more severe asthma [18]. In addition,
allergic rhinitis is also associated with a sub-diagnosis
and under-treatment [19].
We also observed that the perception and the assump-
tion of disease were lower in the undiagnosed asthmatic
population. When we looked at the asthma medication in
people who were not diagnosed, we found that there was a
significant decrease in appropriate treatments. Our study
also show that children with symptomatic asthma but no
diagnosis, had less well-controlled asthma than children
with diagnosed asthma, since their quality of life deter-
mined by nocturnal awakenings and truancy was not opti-
mal [20]. In previous studies, it was shown that the health
implications could be significant in asthmatics without a
proper diagnosis, because they were less treated than diag-
nosed asthmatics [21]: they missed more days of school
because of wheezing, they limited their physical activity,
and their sleep was more disrupted [22].
Our study presents some weaknesses but also many
strengths. The major weakness is that at any step the study
of the 6 cities was intended as a pharmaco-epidemiological
investigation, which reduces the information regarding the
specific treatment(s) taken by children. Our study would
have taken benefit from more details on the dose, start and
end of treatment, and frequency of administration. How-
ever, the questionnaire contained a section asking for
details on asthma and this allowed collecting information
on asthma treatment and compliance and management.
Another bias might arise from the fact that parents of chil-
dren reported treatments and symptoms. No objective data
on treatment and asthma (for example, using the medical
record) were available in the survey. In addition, it would
have been interesting to have additional data on what fac-
tors predispose parents not to treat their children. Another
aspect that may engender biases is that only one year be-
fore the survey was considered. Finally, data collection was
retrospective, which raises the possibility of recall bias. All
these biases preclude a more accurate corroboration of
data and push for caution in interpreting the results. How-
ever, the selection of the population and the use of standar-
dized protocol and instruments in our survey constitute an
added value. In addition, data are original for France wheredata management is still limited to some surveys that did
not specifically target children (www.irdes.fr).
Conclusions
In conclusion, we examined the under-diagnosis of child-
hood asthma and the use of asthma medication in a
population-based sample of schoolchildren. With one-third
of children with symptoms suggestive of asthma who had
no diagnosis of asthma, it remains a disease not controlled
in our sample that was representative. Furthermore, the use
of medication against asthma seems inadequate in the con-
sidered sample both qualitatively (the drugs were not
always appropriate) and quantitatively (some asthmatics
were not treated at all). Similar studies should help improv-
ing the level of intervention and treatment practices in
France. This study constitutes a preliminary attempt to
identify the characteristics of children undiagnosed and/or
untreated for asthma compared to children diagnosed and/
or treated for asthma in Metropolitan France, so as to
emphasize the role of the diagnosis, the treatment, the edu-
cation, and the consensus in the progression of the man-
agement of the asthmatic disease during childhood.
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